Krebs von den Lungen-6 (KL-6), soluble programmed cell death-1 (sPD-1) and its ligand-1(sPDL-1) in systemic sclerosis patients: Relation to disease parameters
- Citation:
- El-Shazly, R., M. H. Niazy, N. M. Riad, F. H. Abdelraouf, and R. M. ElRefai, "Krebs von den Lungen-6 (KL-6), soluble programmed cell death-1 (sPD-1) and its ligand-1(sPDL-1) in systemic sclerosis patients: Relation to disease parameters", The Egyptian Rheumatologist, vol. 44, pp. 333–337, 2022.